ArticlesAbstractPharmacognosy Research,2021,13,1,34-41.DOI:10.4103/pr.pr_69_20Published:April 2021Type:Original ArticleAuthors:Satyawati Rathia, Lowkesh Chandravanshi, Virendra Kumar Kori, Kalpana Patel, and Prashant Kumar Gupta Author(s) affiliations:Satyawati Rathia1, Lowkesh Chandravanshi1, Virendra Kumar Kori2, Kalpana Patel2, Prashant Kumar Gupta1 1Department of Kaumarbhritya, Shri NPA Government Ayurveda College, Raipur, Chhattisgarh, INDIA 2Department of Kaumarbhritya, IPGT and RA, Jamnagar, Gujarat, INDIA Abstract:Background: Increasing rate of emergence of newer infection, resistance to antibiotics, reoccurrence of infections, and malnutrition have created a space for an effective and safe solution of above issues to mankind. Swana Prashana is a unique concept of Indian system of medicine for improving the generalized immunity consequently helping the child to resist and fight against various infection and diseases. Aims: Study was planned to evaluate the efficacy of Swarna Prashana and Swarna Vacha Prashana in infants. Materials and Methods: A randomized, controlled, single-blind clinical study was planned in healthy infants to study the effect of Swarna Prashana in anthropometry, hematological, biochemical, immunological, and infant-toddler quality of life (ITQOL) parameters in 3 differently categorized groups namely Group A: (n = 39, Ghrita and Madhu). Group B: (n = 42, Swarna Bhasma, Ghrita and Madhu) Group C: (n = 38, Swarna Bhasma, Ghrita, Madhu and Vacha Churna). Results: The present clinical study showed statistically highly significant (P < 0.001) increase in all the anthropometrical measurements of infants all three groups. The drugs did not hamper normal growth of the infants and they did not have any additional effect on enhancing the anthropometrical values. Hematological and biological parameters did not show significant difference in comparison in all groups. The results of Renal function and liver function tests were in normal limits after completion of treatment and post treatment follow-up suggestive of safe to be administered in infants. Immunological parameters also did not show significant difference of comparison in all groups except in Group C where immunoglobulin G (IgG), IgM, albumin, globulin levels were increased. Group C significantly improved all the ITQOL parameters while on comparison significant difference was observed in improving the physical abilities only. Conclusion: Current study suggests Swarna Prashana as infants health promotive and morbidity preventive. Author advocates a large scale randomized double blind clinical trial for further validation of impact of Swarna Prashan as mass health-care initiative. Keywords:Ayurveda, Immunomodulation, Swarnaprashan, Vyadhi kshamatvaView:PDF (1.06 MB) PDF Thumbnails Document Outline Search Document Find Toggle Sidebar Previous Next Page: Fullscreen Print Download Current View Zoom Out Zoom In Automatic Zoom Actual Size Fit Page Full Width 50% 75% 100% 125% 150% 200% More Information Less Information Close Click here to download the PDF file. Images Immunological, Biochemical, and Infant‑Toddler Quality of Life Parameter‑Based Study of Swarna Prashana (a Herbo‑Mineral Ayurveda Preparation) in Infants KeywordsAyurvedaImmunomodulationSwarnaprashanVyadhi kshamatva ‹ Antiarthritic and Antinociceptive Potential of Ethanolic Extract from Leaves of Doliocarpus dentatus (Aubl.) Standl. in Mouse Model up Isolation, Method Development, and Validation of Diterpenes in Coffee Oil: Identification by Multiple Reaction Monitoring Approach with Atmospheric Pressure Chemical Ionization Mode ›